To evaluate the effect of EGFR mutation status on the prognostic potential of CEAIn, adenocarcinoma patients were stratified into either EGFR wild-type (n = 190) or EGFR-mutant (n = 327) groups and subjected to multivariable Cox regression analysis. This evidence concerns the gene EGFR and adenocarcinoma.